1
Metastatic Breast Cancer Treatment Planning
Condition(s):Metastatic Breast CancerLast Updated:January 31, 2019Withdrawn
Metastatic Breast Cancer: 4424 Clinical Trials, Page 1 of 443
Hide Studies Not Open or Pending
2
Understanding Value in Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:August 26, 2019Completed
3
Genetic Characteristics of Metastatic Breast Cancer Patients
Condition(s):Metastatic Breast CancerLast Updated:February 6, 2020Recruiting
4
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Condition(s):HER2 Positive Metastatic Breast CancerLast Updated:June 14, 2022Recruiting
5
Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer
Condition(s):HER2 Negative Metastatic Breast CancerLast Updated:April 14, 2016Completed
6
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
Condition(s):HER2-positive Metastatic Breast CancerLast Updated:June 28, 2022Not yet recruiting
7
Management of Metastatic Breast Cancer in Clinical Practice – Retrospective Study
Condition(s):Metastatic Breast CancerLast Updated:August 22, 2013Completed
8
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Condition(s):Metastatic Breast CancerLast Updated:February 23, 2017Completed
9
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:September 9, 2020Completed
10
Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:December 3, 2009Completed